Huihui Chong

1.9k total citations
65 papers, 1.5k citations indexed

About

Huihui Chong is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Huihui Chong has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 56 papers in Virology and 15 papers in Immunology. Recurrent topics in Huihui Chong's work include HIV Research and Treatment (56 papers), HIV/AIDS drug development and treatment (49 papers) and Hepatitis C virus research (10 papers). Huihui Chong is often cited by papers focused on HIV Research and Treatment (56 papers), HIV/AIDS drug development and treatment (49 papers) and Hepatitis C virus research (10 papers). Huihui Chong collaborates with scholars based in China, Switzerland and United States. Huihui Chong's co-authors include Yuxian He, Yuanmei Zhu, Danwei Yu, Sheng Cui, Hongxia Yan, Xue Yao, Zonglin Qiu, Meitian Wang, S. Waltersperger and Youchun Wang and has published in prestigious journals such as Cell, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Huihui Chong

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huihui Chong China 24 1.2k 887 438 328 193 65 1.5k
Leo Heyndríckx Belgium 24 938 0.8× 1.1k 1.2× 236 0.5× 365 1.1× 278 1.4× 63 1.5k
Marguerite Koutsoukos Belgium 18 659 0.5× 1.0k 1.2× 474 1.1× 929 2.8× 544 2.8× 29 1.8k
Li‐Hua Ping United States 8 330 0.3× 532 0.6× 326 0.7× 238 0.7× 208 1.1× 16 910
Elaine Kan United States 20 559 0.5× 868 1.0× 406 0.9× 426 1.3× 276 1.4× 26 1.2k
Dorothy Lang United States 11 443 0.4× 790 0.9× 408 0.9× 351 1.1× 230 1.2× 17 1.2k
Constantinos Kurt Wibmer South Africa 12 972 0.8× 923 1.0× 460 1.1× 593 1.8× 207 1.1× 17 1.7k
Wendy W. Yeh United States 16 491 0.4× 533 0.6× 164 0.4× 295 0.9× 413 2.1× 47 1.1k
Michael W. Cho United States 19 815 0.7× 1.1k 1.2× 421 1.0× 715 2.2× 355 1.8× 36 1.8k
Kelli Greene United States 11 672 0.6× 1.5k 1.7× 390 0.9× 799 2.4× 330 1.7× 17 1.7k
Nicole Back Netherlands 19 1.0k 0.8× 1.2k 1.3× 287 0.7× 198 0.6× 319 1.7× 38 1.4k

Countries citing papers authored by Huihui Chong

Since Specialization
Citations

This map shows the geographic impact of Huihui Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huihui Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huihui Chong more than expected).

Fields of papers citing papers by Huihui Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huihui Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huihui Chong. The network helps show where Huihui Chong may publish in the future.

Co-authorship network of co-authors of Huihui Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Huihui Chong. A scholar is included among the top collaborators of Huihui Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huihui Chong. Huihui Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Nian, Yuanmei Zhu, Huihui Chong, Sheng Cui, & Yuxian He. (2025). Structural characterization of HIV fusion inhibitor LP-98: Insights into antiviral and resistance mechanisms. Antiviral Research. 239. 106190–106190. 1 indexed citations
2.
Xue, Jing, Yuanmei Zhu, Rui Hou, et al.. (2025). An HIV fusion-inhibitory lipopeptide provides robust post-exposure prophylaxis and prevents viral reservoir seeding in macaques. Cell Reports. 44(9). 116228–116228.
3.
Yan, Hongxia, Yuanmei Zhu, Huihui Chong, et al.. (2025). Addition of a short HIV-1 fusion-inhibitory peptide to PRO 140 antibody dramatically increases its antiviral breadth and potency. Journal of Virology. 99(4). e0201824–e0201824. 1 indexed citations
4.
Ding, Xiaohui, et al.. (2024). Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure. Microbes and Infection. 26(8). 105366–105366. 4 indexed citations
5.
Zhu, Yuanmei, et al.. (2024). Development of lipopeptide-based HIV-1/2 fusion inhibitors targeting the gp41 pocket site with a new design strategy. Antiviral Research. 232. 106042–106042. 2 indexed citations
6.
Zhang, Yuanyuan, Huihui Chong, Xiaoyan Hu, et al.. (2023). Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19. Frontiers in Immunology. 14. 1199938–1199938. 4 indexed citations
7.
Zhu, Yuanmei, Yue Hu, Nian Liu, Huihui Chong, & Yuxian He. (2022). Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides. Antiviral Research. 208. 105445–105445. 12 indexed citations
8.
Yan, Hongxia, Tong Tong Wu, Yue Chen, et al.. (2022). Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41. Frontiers in Cellular and Infection Microbiology. 12. 916487–916487. 6 indexed citations
9.
Xue, Jing, Huihui Chong, Yuanmei Zhu, et al.. (2021). Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide. Cell. 185(1). 131–144.e18. 32 indexed citations
10.
Chong, Huihui, Jing Xue, Yuanmei Zhu, et al.. (2019). Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques. PLoS Pathogens. 15(2). e1007552–e1007552. 40 indexed citations
11.
Ding, Xiaohui, Yuanmei Zhu, Huihui Chong, et al.. (2018). Structural and functional characterization of HIV-1 cell fusion inhibitor T20. AIDS. 33(1). 1–11. 39 indexed citations
12.
Chong, Huihui, et al.. (2016). Development of potent and long-acting HIV-1 fusion inhibitors. AIDS. 30(8). 1187–1196. 59 indexed citations
13.
Qiu, Zonglin, et al.. (2015). Identification and characterization of a subpocket on the N-trimer of HIV-1 Gp41. AIDS. 29(9). 1015–1024. 23 indexed citations
14.
Chong, Huihui, et al.. (2014). Two M-T hook residues greatly improve the antiviral activity and resistance profile of the HIV-1 fusion inhibitor SC29EK. Retrovirology. 11(1). 40–40. 24 indexed citations
15.
Chong, Huihui, Xue Yao, Zonglin Qiu, et al.. (2014). The M-T hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance. Journal of Antimicrobial Chemotherapy. 69(10). 2759–2769. 34 indexed citations
16.
Chong, Huihui, et al.. (2014). Design of a highly potent HIV-1 fusion inhibitor targeting the gp41 pocket. AIDS. 29(1). 13–21. 46 indexed citations
17.
Chong, Huihui, Xue Yao, Zonglin Qiu, et al.. (2012). The M-T Hook Structure Is Critical for Design of HIV-1 Fusion Inhibitors. Journal of Biological Chemistry. 287(41). 34558–34568. 50 indexed citations
18.
Chong, Huihui, Xue Yao, Zonglin Qiu, et al.. (2012). Discovery of Critical Residues for Viral Entry and Inhibition through Structural Insight of HIV-1 Fusion Inhibitor CP621–652. Journal of Biological Chemistry. 287(24). 20281–20289. 45 indexed citations
19.
Jia, Leili, Chuanfu Zhang, Yong Wang, et al.. (2010). A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement. Virology Journal. 7(1). 142–142. 3 indexed citations
20.
Zhang, Feng, Xiuhua Li, Zhuo Li, et al.. (2006). Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. Journal of Medical Virology. 78(11). 1441–1448. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leo Heyndríckx Breakdown of academic impact, for papers by Marguerite Koutsoukos Breakdown of academic impact, for papers by Li‐Hua Ping Breakdown of academic impact, for papers by Elaine Kan Breakdown of academic impact, for papers by Dorothy Lang Breakdown of academic impact, for papers by Constantinos Kurt Wibmer Breakdown of academic impact, for papers by Wendy W. Yeh Breakdown of academic impact, for papers by Michael W. Cho Breakdown of academic impact, for papers by Kelli Greene Breakdown of academic impact, for papers by Nicole Back
Rankless by CCL
2026